Cite
HARVARD Citation
Duffaud, F. et al. (2021). Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study. European journal of cancer. pp. 108-118. [Online].